IXIIXICOIXI info
$0.13info0.00%24h
Global rank34070
Market cap$6.06M
Change 7d0.00%
YTD Performance-24.00%
SP500 benchmarkUnderperform
P/E-5.14
P/S0.69
Revenue$8.80M
Earnings-$1.55M
Dividend yield-

IXICO (IXI) Stock Overview

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, and orphan and rare diseases. Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

IXI Stock Information

Symbol
IXI
Address
Griffin CourtLondon, EC1A 9PNUnited Kingdom
Founded
-
Trading hours
8:00 AM - 4:30 PM GMT
Website
https://ixico.com
Country
🇬🇧 United Kingdom
Phone Number
44 20 3763 7499

IXICO (IXI) Price Chart

-
Value:-

IXICO Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.12540095304724316
N/A
Market Cap
$6.06M
N/A
Shares Outstanding
48.31M
0.33%
Employees
89.00
N/A
Shareholder Equity
11.43M
-8.49%
Valuation
2023
Change
P/E Ratio
-5.14
N/A
P/S Ratio
0.69
N/A
P/B Ratio
0.53
N/A
Growth
2023
Change
Return on Equity
-0.1360
N/A
Earnings
2023
Change
Revenue
$8.80M
N/A
Earnings
-$1.55M
N/A
EPS
-0.0244
N/A
Earnings Yield
-0.1946
N/A
Gross Margin
0.4906
N/A
Operating Margin
-0.2156
N/A
Net income margin
-0.1767
N/A
Financial Strength
2023
Change
Total Assets
$17.15M
N/A
Total Debt
$510.84K
N/A
Cash on Hand
$5.32M
N/A
Debt to Equity
0.1799
-21.25%
Cash to Debt
$10.42
-6.84%
Current Ratio
$4.91
-7.97%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org